Quantitative  	Quantitative  	 JJ	B-NP
determination  	determination  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
enantiomers  	enantiomers  	 NN	I-NP
of  	of  	 IN	I-NP
methadone  	methadone  	 NN	I-NP
in  	in  	 IN	O
human  	human  	 JJ	O
plasma  	plasma  	 NN	B-NP
and  	and  	 CC	O
saliva  	saliva  	 NN	O
by  	by  	 IN	O
chiral  	chiral  	 JJ	B-NP
column  	column  	 NN	I-NP
chromatography  	chromatography  	 VBZ	O
coupled  	coupled  	 VBN	O
with  	with  	 IN	O
mass  	mass  	 FW	B-NP
spectrometric  	spectrometric  	 FW	I-NP
detection  	detection  	 FW	I-NP
Methadone  	Methadone  	 NNP	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
potent  	potent  	 JJ	O
lipophilic  	lipophilic  	 JJ	B-NP
synthetic  	synthetic  	 JJ	I-NP
opioid  	opioid  	 NN	I-NP
that  	that  	 WDT	O
is  	is  	 VBZ	O
effective  	effective  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
cancer  	cancer  	 NN	B-NP
pain  	pain  	 NN	I-NP
and  	and  	 CC	O
perceived  	perceived  	 JJ	O
benefit  	benefit  	 NN	O
in  	in  	 IN	O
difficult  	difficult  	 JJ	O
pain  	pain  	 NN	B-NP
control  	control  	 NN	I-NP
scenarios  	scenarios  	 NNS	I-NP
( 	( 	 -LRB-	O
especially  	especially  	 RB	O
in  	in  	 IN	O
cases  	cases  	 NNS	O
of  	of  	 IN	O
neuropathic  	neuropathic  	 JJ	B-NP
pain 	pain 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
methadone  	methadone  	 NN	B-NP
in  	in  	 IN	O
clinical  	clinical  	 JJ	B-NP
practice  	practice  	 NN	I-NP
is  	is  	 VBZ	O
challenging  	challenging  	 VBG	O
however 	however 	 RB	O
,  	,  	 ,	O
due  	due  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
narrow  	narrow  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
window  	window  	 NN	I-NP
and  	and  	 CC	O
large  	large  	 JJ	O
inter-  	inter-  	 JJ	O
and  	and  	 CC	O
intra-individual  	intra-individual  	 JJ	B-NP
variability  	variability  	 NN	I-NP
in  	in  	 IN	O
therapeutic  	therapeutic  	 JJ	B-NP
response 	response 	 NN	I-NP
.  	.  	 .	O
Quantitation  	Quantitation  	 NNP	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
enantiomers  	enantiomers  	 JJ	I-NP
d-  	d-  	 JJ	I-NP
and  	and  	 CC	O
l-methadone  	l-methadone  	 NNP	B-NP
( 	( 	 -LRB-	O
d-  	d-  	 NNP	O
and  	and  	 CC	O
l-MTD 	l-MTD 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
plasma  	plasma  	 NN	B-NP
and  	and  	 CC	O
saliva  	saliva  	 NN	O
provides  	provides  	 VBZ	O
a  	a  	 DT	O
basis  	basis  	 NN	O
for  	for  	 IN	O
studying  	studying  	 VBG	O
its  	its  	 PRP$	O
pharmacokinetics  	pharmacokinetics  	 NN	B-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
for  	for  	 IN	O
monitoring  	monitoring  	 VBG	O
efficacy 	efficacy 	 NN	O
,  	,  	 ,	O
toxicity  	toxicity  	 NN	O
and  	and  	 CC	O
side-effects 	side-effects 	 JJ	B-NP
.  	.  	 .	O
This  	This  	 DT	O
assay  	assay  	 NN	B-NP
involves  	involves  	 VBZ	O
quantitation  	quantitation  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
enantiomers  	enantiomers  	 NN	B-NP
of  	of  	 IN	I-NP
methadone  	methadone  	 NNS	I-NP
using  	using  	 VBG	O
their  	their  	 PRP$	O
respective  	respective  	 JJ	O
deuterated  	deuterated  	 JJ	B-NP
internal  	internal  	 JJ	I-NP
standards 	standards 	 NNS	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
plasma  	plasma  	 NN	B-NP
and  	and  	 CC	O
saliva  	saliva  	 JJ	O
matrices  	matrices  	 NN	O
with  	with  	 IN	O
no  	no  	 DT	O
impact  	impact  	 NN	O
of  	of  	 IN	O
ion  	ion  	 JJ	B-NP
suppression  	suppression  	 NN	I-NP
in  	in  	 IN	O
either  	either  	 DT	O
matrix 	matrix 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
analytical  	analytical  	 JJ	B-NP
recoveries  	recoveries  	 NNS	I-NP
of  	of  	 IN	O
d-  	d-  	 JJ	O
and  	and  	 CC	O
l-MTD  	l-MTD  	 JJ	B-NP
from  	from  	 IN	O
the  	the  	 DT	O
saliva  	saliva  	 JJ	O
collection  	collection  	 NN	O
devices  	devices  	 NNS	O
( 	( 	 -LRB-	O
Salivette® 	Salivette® 	 NNP	B-NP
)  	)  	 -RRB-	O
are  	are  	 VBP	O
optimised  	optimised  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
novel  	novel  	 NN	O
method  	method  	 NN	O
with  	with  	 IN	O
an  	an  	 DT	O
accurate  	accurate  	 JJ	O
and  	and  	 CC	O
simple  	simple  	 JJ	O
extraction  	extraction  	 JJ	B-NP
method  	method  	 NN	I-NP
employing  	employing  	 VBG	I-NP
dichloromethane 	dichloromethane 	 NNS	I-NP
.  	.  	 .	O
Optimal  	Optimal  	 JJ	B-NP
enantioselective  	enantioselective  	 JJ	I-NP
separations  	separations  	 NN	I-NP
were  	were  	 VBD	O
achieved  	achieved  	 VBN	O
using  	using  	 VBG	O
an  	an  	 DT	O
α1-acid  	α1-acid  	 FW	B-NP
glycoprotein  	glycoprotein  	 FW	I-NP
chiral  	chiral  	 FW	I-NP
stationary  	stationary  	 FW	I-NP
phase  	phase  	 FW	I-NP
and  	and  	 FW	O
triple  	triple  	 FW	O
quadrupole  	quadrupole  	 FW	B-NP
tandem  	tandem  	 FW	O
mass  	mass  	 FW	B-NP
spectrometer 	spectrometer 	 FW	I-NP
.  	.  	 .	O
Linearity  	Linearity  	 NNP	B-NP
was  	was  	 VBD	O
demonstrated  	demonstrated  	 VBN	O
over  	over  	 IN	O
0.05-1000µg 	0.05-1000µg 	 NNP	O
/ 	/ 	 NNP	O
L  	L  	 NNP	O
for  	for  	 IN	O
both  	both  	 DT	O
enantiomers  	enantiomers  	 NN	B-NP
in  	in  	 IN	O
plasma  	plasma  	 NN	B-NP
and  	and  	 CC	O
in  	in  	 IN	O
saliva  	saliva  	 NN	O
with  	with  	 IN	O
correlation  	correlation  	 JJ	B-NP
coefficients  	coefficients  	 NN	I-NP
greater  	greater  	 JJR	O
than  	than  	 IN	O
0.998 	0.998 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
lower  	lower  	 JJR	B-NP
limit  	limit  	 NN	I-NP
of  	of  	 IN	I-NP
quantitation  	quantitation  	 NNS	I-NP
( 	( 	 -LRB-	O
LLOQ 	LLOQ 	 NNP	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
determined  	determined  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
0.1µg 	0.1µg 	 NNP	O
/ 	/ 	 NNP	O
L  	L  	 NNP	O
in  	in  	 IN	O
plasma  	plasma  	 NN	B-NP
and  	and  	 CC	O
saliva  	saliva  	 NN	O
for  	for  	 IN	O
d-  	d-  	 JJ	O
and  	and  	 CC	O
l-MTD 	l-MTD 	 JJ	B-NP
.  	.  	 .	O
Accuracy  	Accuracy  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
method  	method  	 NN	I-NP
ranges  	ranges  	 NNS	I-NP
from  	from  	 IN	O
100 	100 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
106 	106 	 CD	O
%  	%  	 NN	O
even  	even  	 RB	O
at  	at  	 IN	O
the  	the  	 DT	O
LLOQ  	LLOQ  	 NNP	B-NP
and  	and  	 CC	O
total  	total  	 JJ	B-NP
precision 	precision 	 NN	I-NP
,  	,  	 ,	O
expressed  	expressed  	 VBN	O
as  	as  	 IN	O
the  	the  	 DT	O
coefficient  	coefficient  	 NN	O
of  	of  	 IN	O
variation 	variation 	 NN	O
,  	,  	 ,	O
was  	was  	 VBD	O
between  	between  	 IN	O
0.2 	0.2 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
4.4 	4.4 	 CD	O
%  	%  	 NN	O
for  	for  	 IN	O
both  	both  	 DT	O
analytes  	analytes  	 NN	B-NP
in  	in  	 IN	O
both  	both  	 DT	O
matrices 	matrices 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
simple  	simple  	 JJ	O
one  	one  	 CD	O
step  	step  	 NN	B-NP
extraction  	extraction  	 NN	I-NP
procedure  	procedure  	 NN	I-NP
resulted  	resulted  	 VBD	O
in  	in  	 IN	O
recoveries  	recoveries  	 NNS	O
greater  	greater  	 JJR	O
than  	than  	 IN	O
95 	95 	 CD	O
%  	%  	 NN	O
for  	for  	 IN	O
both  	both  	 DT	O
analytes 	analytes 	 NN	B-NP
,  	,  	 ,	O
at  	at  	 IN	O
concentrations  	concentrations  	 NNS	B-NP
as  	as  	 IN	O
low  	low  	 JJ	O
as  	as  	 IN	O
0.5µg 	0.5µg 	 NNP	O
/ 	/ 	 NNP	O
L 	L 	 NNP	O
,  	,  	 ,	O
from  	from  	 IN	O
the  	the  	 DT	O
Salivette® 	Salivette® 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
validated  	validated  	 JJ	O
method  	method  	 NN	O
was  	was  	 VBD	O
applied  	applied  	 VBN	O
successfully  	successfully  	 RB	O
in  	in  	 IN	O
14  	14  	 CD	O
paired  	paired  	 CD	B-NP
plasma  	plasma  	 NNS	I-NP
and  	and  	 CC	O
saliva  	saliva  	 JJ	O
samples  	samples  	 NNS	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
adult  	adult  	 NN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
cancer  	cancer  	 NN	B-NP
pain  	pain  	 NN	I-NP
receiving  	receiving  	 VBG	I-NP
methadone 	methadone 	 NNS	I-NP
.  	.  	 .	O
